Leap Therapeutics (LPTX) Misses Q3 EPS by 8c Nov 12, 2025 04:24PM
Leap Therapeutics (LPTX) Misses Q2 EPS by 40c Aug 14, 2025 07:43AM
Leap Therapeutics (LPTX) Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives Jun 23, 2025 07:01AM
Leap Therapeutics (LPTX) Misses Q1 EPS by 37c May 13, 2025 07:52AM
Purple Biotech Ltd. (PPBT) Appoints Shai Lankry as CFO May 12, 2025 07:31AM


Mar 27, 2025 06:41AM H.C. Wainwright Reiterates Neutral Rating on Leap Therapeutics (LPTX)
Mar 26, 2025 07:01AM Leap Therapeutics (LPTX) Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study
Jan 29, 2025 06:40AM H.C. Wainwright Downgrades Leap Therapeutics (LPTX) to Neutral
Jan 28, 2025 08:16PM Baird Downgrades Leap Therapeutics (LPTX) to Neutral
Jan 28, 2025 07:03AM Leap Therapeutics (LPTX) Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
Nov 13, 2024 04:13PM Leap Therapeutics (LPTX) Misses Q3 EPS by 44c
Aug 12, 2024 08:00AM Leap Therapeutics (LPTX) Misses Q2 EPS by 52c